THANK YOU FOR SUBSCRIBING
"Emme is the first company to offer a comprehensive and complete birth control solution," stated Christine Aylward, Founder and Managing Partner of Magnetic Ventures.
FREMONT, CA: Emme, a healthcare technology company focused on women's health, declared the launch of the Emme Smart Case, an integrated solution designed to reduce the 9 percent failure rate of birth control pills. The smart technology device gives a solution to the most significant issue with birth control pills women face - pill adherence.
The company also raised $2.5M in seed funding led by Magnetic Ventures with active participation from existing investors. The firm's founding partner, Christine Aylward, joined the board, along with experienced healthcare innovator and Evidation CEO Deborah Kilpatrick. Christine and Deborah bring to Emme experience and expertise in the medical device, digital health, and pharmaceutical industries.
Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.
Approximately 10 million women take the pill in the United States each year for contraception and health management. Although the pill should be taken on time every day to be effective, 80 perfect of women miss at least one pill per month. "Emme is the first company to offer a comprehensive and complete birth control solution," stated Christine Aylward, Founder and Managing Partner of Magnetic Ventures. "Many companies deliver pills, but no other company can tell you when to take the pill, and when you should use back-up contraception to help avoid getting pregnant. It may seem simple to be compliant with pill management - but pregnancy rates while on the oral contraception prove it's not."
People on the pill currently depend on alarms, memory, or apps. Unfortunately, missed pills are prevalent with these solutions because they are subject to alarm fatigue and user error. Motivated to resolve this pressing healthcare issue, Amanda French and Janene Fuerch, MD, co-founded Emme in 2017 during their fellowship at Stanford Byers Center for Biodesign. "Missed pills result in nearly one million unplanned pregnancies in the United States each year. They also disrupt hormone balance causing side effects such as bleeding, nausea, mood changes, and headaches," French added. "After hearing stories from hundreds of women about the stress of the pill, I knew we could help improve the effectiveness of the pill by solving the problem of adherence with technology."
More in News